v" The cardiorespiratory effects of a nonlethal venous air embolism were studied in dogs in the presence of a perfluorocarbon emulsion (PFE). Prior to embolization, five dogs received 20 cc/kg of hydroxyethyl starch (6% HES) and five received PFE oxypherol (20% FC-43). Determinations of mean systemic arterial pressure (MAP), pulmonary artery pressure (PAP), left ventricular pressure (LVP), first and second derivatives of LVP with respect to time (dP/dt and Vmax), cardiac index (CI), stroke index, left and right ventricular stroke work index (LVSWI and RVSWI), PaCO2, PaO2, and venous admixture (Qs/Qt) were made before and then 1, 5, 10, and 30 minutes after placement of the venous air emboli (0.75 cc/kg/min for 5 minutes). After emboli were introduced, PaO2, MAP, LVSWI, dP/dt, Vmax, and CI decreased; the average decrease during the first 5 minutes was significantly less in the PFE group. Following introduction of venous air emboli, PAP, PaCO2, RVSWI, and Qs/Qt increased less in the PFE group than in the HES group, with statistical significance achieved at various times during the first 10 minutes after embolism. All parameters returned toward baseline values by 30 minutes in both groups. This study indicates that FC-43, when administered before venous air embolism, helps to attenuate some of the detrimental cardiorespiratory effects of the embolism.
V
ENOUS air embolism (VAE) is a well-recognized potential complication associated with many procedures performed in a modern neurosurgical practice. There is a risk of VAE in procedures where there is an open venous lumen under negative pressure relative to atmospheric pressure. Venous air embolism is reported to occur in 25% to 40% of patients undergoing neurosurgery in the seated position. 2 The pathophysiology of VAE has been shown to depend on both the rate of embolism as well as total volume. Hemodynamic changes may range from mild elevations in pulmonary arterial pressure (PAP) to severe systemic hypotension and cardiac arrest. Because of the potentially devastating effects of VAE, current management of this problem stresses early detection and prevention of massive emboli. 6 However, with the exception of evacuation of air already embolized to the right side of the heart and discontinuation of nitrous oxide, currently recommended therapeutic techniques do not offer a modality for decreasing the size of venous air emboli or for improving perfusion to occluded pulmonary arterial beds.
Perfluorocarbon emulsions (PFE's) have attracted attention in recent years because of their ability to passively transport oxygen, due to an increased solubility of this gas in perfluorocarbons as compared to plasma? '8 Oxygen may be dissolved in quantities of up to 60 vol% in some pure PFE's. In contrast, whole blood may contain 20 vol% 02 and plasma only 0.3 vol%. Twenty vol% PFE may carry up to 7 vol% 02 at 30~ and one atmosphere. The PFE's have been widely tested as blood substitutes and plasma expanders? Similar accentuated solubilities of CO27 and nitrogen have been demonstrated; nitrogen has a solubility of approximately 50 vol% in pure PFE (unpublished data, Alpha Therapeutic Corp., Los Angeles, California). Speed of gas diffusion into PFE has been shown to be not significantly different from gas diffusion into plasma. 7 Uptake and release of gases follow partial pressure gradients and are therefore linear with respect to gas tensions. Perfluorocarbons do not form stable emulsions, and alone are immiscible with plasma, so that an emulsifying agent (Pluronic F-68) is added. The addition of this polyoxyethylene decreases the emulsion's viscosity as compared to whole blood.Z~ The PFE consists of small Effect of perfluorocarbon emulsion on air embolism in dogs particles (about 70 to 80 times smaller than erythrocytes), thus increasing the surface area available for gas absorption.~2
Enhanced gas solubilities, combined with rapid diffusion of gases across a massively increased surface area, suggest that PFE may be useful in the contraction and dissolution of venous air embolism. In addition, because of a reduced blood viscosity and altered blood theology, 7 improved perfusion might occur in and around areas where VAE has partially occluded the pulmonary arterial tree.
Prior studies in this laboratory have demonstrated that PFE significantly increased the time to death after lethal VAE was administered to rabbits, as well as increasing the total volume of air needed to cause death? Because of this prior work and the above considerations, this study was undertaken to identify which cardiorespiratory derangements seen in nonlethal VAE were attenuated by PFE and to determine the degree of that attenuation.
Materials and Methods
Ten overnight-fasted mongrel dogs (weighing 16 to 25 kg each) were anesthetized with pentobarbital (30 mg/kg), positioned supine, and mechanically ventilated with 100% 02 via an orotracheal tube using a Servoventilator* to achieve a baseline PaCO2 of 32 ___ 5 torr. The left femoral vein was cannulated for infusion of fluids and drugs. To maintain minute ventilation constant, spontaneous breathing was eliminated by producing neuromuscular blockade with intravenous pancuronium bromide (0.15 mg/kg), and adequate relaxation was maintained with supplemental doses as needed. A surface electrocardiogram (EKG) with a left lateral chest lead was used to monitor the dogs. The right femoral artery was cannulated with a No. 7 French pigtail catheter which was passed retrograde into the left ventricle. The left femoral artery was cannulated for measurement of systemic arterial pressure and arterial blood gases.t The first derivative of the left intraventricular pressure (dP/dt) was electrically differentiated. A No. 7 French pulmonary artery thermodilution catheter~ was inserted via cutdown into the fight jugular vein using a sheath introducer. All catheters were connected to pressure transducers and recordings were made on a polygraph.w * Servo-ventilator, Model 900 C, manufactured by Siemens-Elema Corp., Solna, Sweden. The dogs were then assigned to one of two groups of five each: a control group, receiving a venous infusion given over 30 minutes of 20 cc/kg of 6% hydroxyethyl starch (HES),II with 28 mg% CaC12 added to make an equivalent concentration to that in the PFE group; and an experimental group, receiving 20 cc/kg of 20% PFE oxypherol (FC-43)* infused over 30 minutes. In all animals, baseline values of arterial pressure, right atrial pressure, PAP's, pulmonary artery occlusion pressures, left intraventricular pressures, dP/dt, and EKG tracings were recorded. Thermodilution cardiac output, arterial blood gases, and mixed venous blood gases were also determined. The above parameters were measured after an equilibration period of 45 minutes after either pretreatment infusion regimen was completed. Derived values of venous admixture (Qs/Qt), cardiac index, stroke index, left and right ventricular stroke work index (LVSWI and RVSWI), and systemic and pulmonary vascular resistance index (SVRI and PVRI) were calculated using standard formulas.
Venous air embolism was then administered via the introducer catheter into the right internal jugular vein at a rate of 0.75 cc/kg/min for 5 minutes. Paired arterial and mixed venous blood gases and thermodilution cardiac output were measured at 1, 5, 10, and 30 minutes after the air infusion was completed. In addition, pulmonary arterial pressures, right atrial pressures, left ventricular pressures, dP/dt, systemic arterial pressures, [I Hetastarch (6%) in 0.9% normal saline manufactured by American McGaw, Division of American Hospital Supply Corp., Irvine, California.
* FC-43 oxypherol manufactured by Alpha Therapeutic Corp., Los Angeles, California. and surface EKG were measured and recorded continuously. Derived hemodynamic values were also calculated at the four times post-VAE.
Data for pre-and post-volume expansion were compared using two-way analysis of variance for repeated measures. The differences from post-volume expansion values for each parameter were determined and these differences were compared at 1, 5, 10, and 30 minutes following VAE using two-way analysis of variance for repeated measures. Statistical significance between mean differences within groups was determined using the Newman-Kuels method. A probability level of Effect of perfluorocarbon emulsion on air embolism in dogs less than 0.05 (p < 0.05) was considered statistically significant.
Results
Prior to volume expansion, there were no statistically significant differences in any of the cardiorespiratory parameters, measured or derived, between the dogs designated to be in either the PFE group or the hetastarch (HES) group. After volume expansion, there were statistically significant differences in mean systemic arterial pressure (MAP), stroke index, LVSWI, and Qs/Qt between the two groups before VAE was administered ( Table 1) .
Administration of VAE to a supine dog via the right internal jugular vein produced a characteristic pattern of alteration in hemodynamics, PaO2, PaCO2, and in--J~ 4 trapulmonary shunting that returned toward preem-_ -3o_ 4 bolic values by 30 minutes in both groups. The average ~ -50-E differences between post-volume expansion, preem-~ -robolic cardiorespiratory values, and those at various times after VAE are shown in Table 2 with their stando ~ -90-ard errors, g -rioSystemic arterial 02 tensions fell dramatically in the --first few minutes after VAE. There was a statistically ~ -~3o-: significantly greater fall in PaO2 at 1, 5, and 10 minutes z .
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after VAE in the HES group; by 30 minutes there was -tro-, no significant difference between groups (Fig. 1) . Intra--_~ pulmonary shunting increased dramatically immedi- The group receiving PFE had no increase in Qs/Qt at any time, and this difference compared to the HES -io-* o N -group was statistically significant at 1 minute post-VAE o, e - (Fig. 1) . After VAE, PaCO2 markedly increased from *-the control level in both the HES and PFE groups. At _z 6-5, 10, and 30 minutes post-VAE, the elevation in PaCO2 '~ z in the HES group was statistically significantly greater = u than in the PFE group (Fig. 1) . aMean arterial pressure fell after VAE in both the HES and PFE groups. The decrease in MAP after VAE was -~ greater at all times in the HES group compared to the a PFE group. This was statistically significant at 1 minute post-VAE, and the rate of recovery toward control 6-values was faster in the PFE group (Fig. 2) . Similarly, ~ 4-PAP rose in both groups shortly after VAE, and al-~, though the PFE group tended to have less of an increase 8 2-in PAP at 5, 10, and 30 minutes, the differences from z the HES group were statistically significant only at 10 "' o r minutes post-VAE.
-rAlthough pre-VAE values of heart rate tended to be ~' -2-higher in the PFE group than in the HES group, greater decreases were observed at 1, 5, and 10 minutes after VAE in the HES group than in the PFE group. Several of the HES animals were noted to have EKG changes beginning as early as 1 minute after VAE. These changes included depression of the ST segment and T wave inversion, and were not seen in the PFE group. Both groups of dogs were noted to have premature ventricular beats for a short period after VAE.
Parameters of left ventricular function revealed significant maintenance of that function in the PFE group. The first and second derivatives of left ventricular pressure with respect to time (dP/dt and Vm~x) decreased abruptly by nearly 50% of control values in the HES group and slowly recovered toward control values over 30 minutes. There was a statistically greater decrease in dP/dt and in Vma x at 1 and 5 minutes post-VAE in the HES group compared to the PFE group. At 10 minutes, the depression of dP/dt and Vm~x were greater in the HES group, but the difference was not statistically A. B C. significant. At 30 minutes, both Vr, ax and dP/dt returned to baseline values (Fig. 2) .
Cardiac index was determined with the thermodilution method using a pulmonary artery catheter. Independent studies in this laboratory have shown that these values correlate well with aortic blood flow measured with a magnetic flow probe around the proximal aortic root even in the presence of VAE. Cardiac index fell immediately after VAE, then gradually recovered to control values in both groups. The depression in cardiac index from baseline was statistically greater at l and 5 minutes in the HES group compared to the PFE group. In both groups, cardiac index began its recovery toward baseline at 30 minutes post-VAE (Fig. 2) . No statistically significant differences in changes in stroke index were seen between the two groups.
The LVSWI fell dramatically in the HES group after VAE, and the decreases from control levels were statistically significantly greater in the HES group compared to the PFE group at 1 and 5 minutes. Furthermore, the decreases in LVSWI were greater in the HES group than in the PFE group at all times (Fig. 2) . The RVSWI was increased from control in both groups at 1 and 5 minutes after VAE and thereafter returned toward control values. Although not statistically significant, the increases in RVSWI (from control) were greater in the lIES group than in the PFE group at 5, 10, and 30 minutes post-VAE.
No significant change in SVRI was seen between the two groups at any time. The SVRI fell dramatically from control values after VAE in both groups, then gradually increased toward control values by 30 minutes post-VAE. Pulmonary vascular resistance index (PVRI) increased from control levels in both groups at 1, 5, and 10 minutes after VAE, and returned toward baseline by 30 minutes. Although the PVRI increased more in the HES group than in the PFE group during the first l0 minutes post-VAE, the difference was not statistically significant.
Discussion
The model of venous air embolism that was studied produced a characteristic pattern of changes in cardiorespiratory variables. There were significant differences between the animals receiving HES and those receiving PFE both before and after VAE. The preembolism differences in MAP, stroke index, left ventricular end diastolic pressure (LVEDP), LVSWI, and Qs/Qt between groups are attributable to properties of PFE's. The slightly lower MAP and LVEDP and elevated heart rate and PVRI in the PFE group are probably a consequence of histamine release after administration of oxypherol. This phenomenon has been reported previously and is a consistent finding when this PFE is administered to dogs, ]~ but is not observed in other species (cats, rabbits, rats, monkeys, or humans). The pre-embolic LVSWI was statistically less after PFE administration, probably on the basis of the lowered MAP and stroke index used to calculate this derived variable. Since there was no significant difference in contractility (dP/dt and Vm~x) between the groups after volume expansion, the decreases in stroke index seen after PFE administration are probably related to decreases in preload (LVEDP) due to histamine-related venodilation. Measurement of shunt fraction (Qs/Qt) is dependent on accurate determinations of arterial, venous, and capillary oxygen content. In the presence of PFE, although measurement of hemoglobin saturation is accurate, the calculated arterial, capillary, and venous oxygen content is systematically in error because the amount of oxygen dissolved is not 0.0031 times oxygen tension. The solubility coefficient of oxygen in blood containing PFE is not 0.0031, but rather some larger number that depends on the "fluorocrit" in a given sample, on the temperature, and on the particular PFE involved. This is the most likely reason that there was a slightly increased calculated pre-embolic Qs/Qt after PFE administration compared to HES. Attempts to mathematically correct absolute shunt values or physiologically to equalize the other variables in the two groups were not made, since we chose to compare differences between post-volume expansion, pre-embolic values, and those at various times after VAE was administered.
The initial abrupt increase in PAP seen after VAE probably results from constriction of the pulmonary vasculature, leading to reflex shunting of blood within the lung, a concept consistent with the changes seen in blood gas values. Dispersion and contraction of VAE due to absorption of embolized gas into the many small particles of the PFE phase, as well as improved perfusion around partial obstruction in the pulmonary arterial tree due to the emulsion's improvement in viscosity, coupled with enhanced 02 transport, may explain the maintenance of PaO2 and prevention of a large increase in intrapulmonary shunt when VAE was administered in the PFE-treated animals. Similarly, smaller increases in dead space effect should occur after VAE in PFEtreated animals and, although dead space measurements were not made in this study, the trends noted in PaCO2 would support this, assuming that minute ventilation and CO2 production were constant during the study period.
It is presumed that contraction and/or dissolution of VAE into the PFE phase, either by reducing the degree of pulmonary vascular obstruction to left heart filling, or by diminishing sympatholytic reflexes initiated by receptors in the pulmonary vasculature, prevents the major decreases in ventricular performance (cardiac index, V .... dP/dt, LVSWI) and arterial blood pressure otherwise seen. Maintenance of excellent oxygen transport to an overburdened ventricular muscle mass also may have played a role. Transfer of air (primarily nitrogen) into the PFE phase may have been enhanced by having a large gradient for nitrogen across the VAE-PFE interface due to the use of 100% 02, resulting in nearly complete denitrogenation of blood (and PFE) before the onset of VAE. Likewise, the large increase in RVSWI seen after VAE may be lessened in the presence of PFE due to attenuation of pulmonary vascular constriction and obstruction, resulting in a smaller increase in right ventricular afterload. The relative cardiac slowing seen in the HES group may represent a larger cardiovascular insult or it may be that the elevations in pre-embolism heart rate in the PFE group helped maintain post-VAE heart rate in that group. Additionally, the slower heart rates seen in the HES group may have allowed for more diastolic fiUing and thus minimized the observed difference in stroke index between the groups.
The emulsifying agent Pluronic F-68 has been implicated in favorably changing blood theology. H Prior studies from this laboratory, 9 which investigated survivability of rabbits after VAE, found no evidence that Pluronic F-68 had any effect in this regard. This agent alone is therefore unlikely to be responsible for the results obtained.
In addition to ameliorating the cardiovascular response to VAE, administration of PFE before onset of VAE involves an augmented intravenous fluid loading, which has been shown to be effective in preventing systemic air embolism during neurosurgical operations performed on patients in the seated position)
In summary, our results indicate that the perfluorocarbon FC-43, when administered before VAE occurs, helps attenuate some of the embolism's detrimental effects, preserving cardiorespiratory function. The exact protective mechanism(s) of PFE during VAE remains to be elucidated although, as discussed above, there are many theoretical reasons why PFE should be useful in this setting. We are currently investigating the usefulness of PFE as a treatment of VAE.
